Katz, M., Califf, R. M, Sun, J., McMurray, J. J, Thomas, L. & Lopes, RD. (2015). Venous thromboembolism and cardiovascular risk: Results from the NAVIGATOR trial. American Journal of Medicine,128(3), 297-302. United States: Elsevier Inc.. Retrieved from https://doi.org/10.1016/j.amjmed.2014.08.022
Contemporary studies suggest an association between venous thromboembolism and a higher incidence of major cardiovascular events, mostly attributed to arterial atherothrombosis. Using data from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research ( NAVIGATOR ) trial, we assessed the association of venous thromboembolism with major cardiovascular events.
Mary MacKillop Institute for Health Research
Access may be restricted.